Agenix

Positive results reported in trial of imaging device for pulmonary embolism diagnosis

Published in Medical Imaging Law Weekly, April 4th, 2006

Agenix has completed a phase 1b pulmonary embolism (PE - blood clot in the lung) trial in Australia in a comparative study against computed tomography pulmonary angiography (CTPA) demonstrating that ThromboView has the potential to be highly beneficial in the diagnosis of PE.

Images acquired in this safety study, which evaluated 14 patients, all positive for PE by CTPA diagnosis, demonstrated high concordance between ThromboView images and CTPA findings. As part of this study, an analysis was performed by independent nuclear medicine specialists who were unaware of the detailed CTPA findings. This independent analysis confirmed a higher than expected sensitivity of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Imaging Law Weekly

Source: Medical Imaging Law Weekly (2006-04-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry